Reply  by Durandy, Yves et al.
equate systemic perfusion, and it is
called “full flow,” it is far from the
physiologic value of 3.5 to 5.0 L 
m2  min1. In most hospitals the
so-called “full flow” is reduced dur-
ing the central part of the procedure
to a low flow or to circulatory arrest.
The types of damage induced by
flow reduction (metabolic derange-
ment; endothelial lesions; vascular,
myocardial, neurologic, hemato-
logic, and respiratory impairment)
are not much different from those
induced by temperature reduction.3,4
In fact, I learned from the Paris
group to perfuse the children with a
flow of 3.0 to 3.5 L  m2  min1,
arbitrarily called “high flow.”
2. Hematocrit. The negative conse-
quences of a systemic perfusion with
low hematocrit, widely know for a
long time,3,4 are now acknowledged
even by Jonas. After years suggest-
ing that perfusion with high hemodi-
lution (hematocrit value around
20%) should be used, his group5 is
now providing evidence of better
neurologic protection with a hemat-
ocrit value of 30%. From the Paris
group I learned to maintain the he-
matocrit value at least at 30% during
cardiopulmonary bypass.
3. Leukocyte depletion. The role of
leukocyte activation as the main
cause of the postoperative inflamma-
tory syndrome, frequently observed
in the pediatric population, is gener-
ally well known, even if leukocyte
depletion is not yet used globally.
In summary, cardiopulmonary bypass as
used by the Paris group is not only normo-
thermic, but also associated with high flow,
high hematocrit, and leukocyte depletion.
In their reply to the letter, Jonas, New-
burger, and Bellinger2 suggested two main
objections: a small margin of safety in the
event of equipment failure and inadequate
surgical exposure.
1. Small margin of safety. The inci-
dence of “equipment failure” on car-
diopulmonary bypass reported in the
literature is between 1 every 1,000 or
10,000 procedures. Even if we con-
sider these figure as an underestima-
tion of the reality, this percentage is
much lower than the percentage of
children with low cardiac output,
need for extensive inotropic and re-
spiratory support, neurologic com-
plications, and the related mortality
and morbidity reported even in the
best centers after “conventional”
cardiopulmonary bypass.
2. Inadequate surgical exposure. The
good results of both the experience
of the Paris group1 with neonates
and infants with cyanotic congenital
heart defects (tetralogy of Fallot,
transposition of the great arteries)
and our more limited personal expe-
rience including infants with total
anomalous pulmonary venous con-
nection3,4 demonstrate the feasibility
of the technique. Of course, it is nec-
essary to have adequate venous
drainage, perfect surgical exposure,
and a surgeon ready to accept some
discomfort for himself (or herself)
rather than for the patients.
In conclusion, Durandy, Hulin, and
Lecompte are to be gratefully acknowl-
edged for teaching all of those involved in
the care of children with congenital heart
defects that surgery for congenital heart
disease can and should be performed with a
perfusion much closer to the physiologic
condition.
Antonio F. Corno, MD, FRCS, FETCS
Cardiovascular Surgery
Centre Hospitalier Universitaire Vaudois
(CHUV)
46 rue du Bugnon
CH-1011, Lausanne, Switzerland
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Reply to the Editor:
We thank Corno for his comments on our
recent letter. Obviously, normothermic car-
diopulmonary bypass associated with
warm blood cardioplegia is only part of the
perfusion protocol. The flow and the hemo-
globin level must be adapted to the sys-
temic oxygen consumption. The quality of
the donor blood product must be optimal,
but we must also stress the importance of a
low volume of priming fluid. We use 180
mL for neonates and infants with a body
surface area up to 0.27 m2 (4.5-5 kg) and
225 mL for infants up to 0.42 m2 (8-8.5
kg). We increase this volume progressively
to obtain a 600-mL prime volume for chil-
dren from 0.85 to 1.6 m2 (20-60 kg). With
this protocol we never use ultrafiltration
during or after bypass.
It is true that most of the surgeons who
visited us have been convinced by the ad-
vantages of this protocol and have changed
their minds about normothermic perfusion.
Several surgical units are now using this
method. We are reluctant to perform a pro-
spective randomized trial comparing hypo-
thermic and normothermic perfusion. We
hope that, in the not too distant future, we
will have enough data to publish a single-
center or a multicenter experience about
normothermic cardiopulmonary bypass in
pediatric surgery.
Yves Durandy, MD
Sylvie Hulin, MD
Yves Lecompte, MD
ICPS—Institut Jacques Cartier
Avenue du Noyer Lambert
Massy, France
12/8/126387
Letters to the Editor
The Journal of Thoracic and Cardiovascular Surgery ● Volume 124, Number 4 857
